This week, we explore what’s speeding up trials, shaking up regulations, and forcing innovators to rethink validation—from LATAM to global markets: Colombia debuts a fully integrated theranostics trial hub Brazil overhauls medical cannabis with pharma-grade precision Needle-free vaccine tech gets $9
AI · isotopes
This week, we explore what’s speeding up trials, shaking up regulations, and forcing innovators to rethink validation—from LATAM to global markets:
Colombia debuts a fully integrated theranostics trial hub Brazil overhauls medical cannabis with pharma-grade precision Needle-free vaccine tech gets $90M backing to scale up An emerging market’s AI-driven research push targets earlier diagnostics
Big risks. Bigger opportunities. Let's unpack them.
← All Global Trial Accelerators editions · Contact bioaccess®